Bone marrow stem cells and liver disease [4]

Gut

Volumn 56, Issue 11, 2007, Pages 1640-

  Lyra, Andre Castro ^a,c   Soares, Milena Botelho Pereira ^b   Dos Santos, Ricardo Ribeiro ^b   Lyra, Luiz Guilherme Costa ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATION; CHRONIC LIVER DISEASE; CLINICAL TRIAL; FEASIBILITY STUDY; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; BONE MARROW TRANSPLANTATION; LIVER REGENERATION; METHODOLOGY; NOTE; PHYSIOLOGY; STEM CELL TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; HUMANS; LIVER REGENERATION; STEM CELL TRANSPLANTATION;

EID: 38049178120     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Gordon MY, Levicar N, Pai M, et al. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006;24:1822-30.
2. Terai S, Ishikawa T, Omori K, et al. Improved liver fonction in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292-8.
3. Lyra AC, Soares MB, da Silva LF, et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007;13:1067-73.